Lebwohl David

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lebwohl David's trades of Intellia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-05
PlS Planned sale
87,232 +10.4%
458.40
US$362,313 		87,232 +10.4% 458.40 US$362,313
2025-01-07 2025-01-03
S Sale
71,973 -46.9%
215.95
US$2,534,173 		71,973 -46.9% 215.95 US$2,534,173
2024-01-05 2024-01-03
S Sale
34,978 +13.3%
333.46
US$2,596,651 		34,978 +13.3% 333.46 US$2,596,651
2023-01-06 2023-01-04
S Sale
2,574 -9.1%
37.21
US$95,779 		2,574 -9.1% 37.21 US$95,779
2022-03-03 2022-01-01
S Sale
1,051 -8.8%
112.24
US$117,964 		1,051 -8.8% 112.24 US$117,964
2021-11-09 2021-11-05
PlS Planned sale
200 -2.2%
135.34
US$27,068 		200 -2.2% 135.34 US$27,068
2021-11-09 2021-11-05
PlS Planned sale
548 -5.8%
134.07
US$73,470 		548 -5.8% 134.07 US$73,470
2021-11-09 2021-11-05
PlS Planned sale
452 -4.6%
132.62
US$59,944 		452 -4.6% 132.62 US$59,944
2021-11-09 2021-11-05
PlS Planned sale
1,200 -10.8%
131.71
US$158,052 		1,200 -10.8% 131.71 US$158,052
2021-10-15 2021-10-14
PlS Planned sale
250 -2.8%
130.47
US$32,618 		250 -2.8% 130.47 US$32,618
2021-10-15 2021-10-14
PlS Planned sale
525 -5.5%
129.83
US$68,161 		525 -5.5% 129.83 US$68,161
2021-10-15 2021-10-14
PlS Planned sale
225 -2.3%
129.01
US$29,027 		225 -2.3% 129.01 US$29,027
2021-10-15 2021-10-14
PlS Planned sale
849 -8.0%
127.81
US$108,511 		849 -8.0% 127.81 US$108,511
2021-10-15 2021-10-14
PlS Planned sale
551 -5.0%
126.92
US$69,933 		551 -5.0% 126.92 US$69,933